BioVie, Inc. (BIVI)
2.16
-0.03
(-1.37%)
USD |
NASDAQ |
Aug 28, 16:00
2.17
+0.01
(+0.46%)
After-Hours: 20:00
BioVie 1 Year Total Returns (Daily) : 45.95% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 45.95% |
| August 27, 2026 | 35.19% |
| August 26, 2026 | 33.54% |
| August 25, 2026 | 26.67% |
| August 24, 2026 | 33.75% |
| August 21, 2026 | 28.29% |
| August 20, 2026 | 19.23% |
| August 19, 2026 | -15.72% |
| August 18, 2026 | -44.89% |
| August 17, 2026 | -29.09% |
| August 14, 2026 | -15.66% |
| August 13, 2026 | -8.24% |
| August 12, 2026 | -6.59% |
| August 11, 2026 | -29.05% |
| August 10, 2026 | -34.13% |
| August 07, 2026 | -65.66% |
| August 06, 2026 | -65.47% |
| August 05, 2026 | -58.87% |
| August 04, 2026 | -69.50% |
| August 03, 2026 | -73.13% |
| July 31, 2026 | -74.69% |
| July 30, 2026 | -78.56% |
| July 29, 2026 | -81.91% |
| July 28, 2026 | -81.27% |
| July 27, 2026 | -81.68% |
| Date | Value |
|---|---|
| July 24, 2026 | -81.85% |
| July 23, 2026 | -82.52% |
| July 22, 2026 | -83.64% |
| July 21, 2026 | -82.35% |
| July 20, 2026 | -84.16% |
| July 17, 2026 | -77.64% |
| July 16, 2026 | -76.47% |
| July 15, 2026 | -74.68% |
| July 14, 2026 | -76.13% |
| July 13, 2026 | -77.03% |
| July 10, 2026 | -70.01% |
| July 09, 2026 | -72.17% |
| July 08, 2026 | -74.26% |
| July 07, 2026 | -73.33% |
| July 06, 2026 | -78.12% |
| July 02, 2026 | -79.91% |
| July 01, 2026 | -76.58% |
| June 30, 2026 | -79.03% |
| June 29, 2026 | -80.10% |
| June 26, 2026 | -81.16% |
| June 25, 2026 | -82.72% |
| June 24, 2026 | -82.06% |
| June 23, 2026 | -80.79% |
| June 22, 2026 | -81.16% |
| June 18, 2026 | -83.85% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 80.24% |
| Amgen, Inc. | 55.58% |
| Anika Therapeutics, Inc. | 128.6% |
| BioCryst Pharmaceuticals, Inc. | 15.94% |
| Imunon, Inc. | -73.47% |